Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin.
about
Accurate molecular classification of renal tumors using microRNA expressionMicro-RNAs as potential new molecular biomarkers in oncology: have they reached relevance for the clinical imaging sciences?MicroRNA expression profiling in archival tissue specimens: methods and data processing.MicroRNAs as lung cancer biomarkersThe role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer.Validation and reproducibility of a microarray-based gene expression test for tumor identification in formalin-fixed, paraffin-embedded specimens.Novel microRNA-based assay demonstrates 92% agreement with diagnosis based on clinicopathologic and management data in a cohort of patients with carcinoma of unknown primaryRegulation of cancer metastasis by cell-free miRNAs.MicroRNA profiling for the identification of cancers with unknown primary tissue-of-originPerformance and clinical evaluation of the 92-gene real-time PCR assay for tumor classification.Tissue slide-based microRNA characterization of tumors: how detailed could diagnosis become for cancer medicine?MicroRNAome genome: a treasure for cancer diagnosis and therapy.MicroRNA as tools and therapeutics in lung cancerA second-generation microRNA-based assay for diagnosing tumor tissue origin.Immunopathologic processes in sympathetic ophthalmia as signified by microRNA profilingCancer of unknown primary ultimately diagnosed as male breast cancer: A rare case report.Molecular classification of cancer with the 92-gene assay in cytology and limited tissue samples.A multicenter study directly comparing the diagnostic accuracy of gene expression profiling and immunohistochemistry for primary site identification in metastatic tumors.High-content affinity-based proteomics: unlocking protein biomarker discovery.MicroRNA profiling in cancer.Role of ancillary studies in fine-needle aspiration from selected tumors.Hide and seek: tell-tale signs of breast cancer lurking in the blood.Gene expression-based diagnostics for molecular cancer classification of difficult to diagnose tumors.Overview of various techniques/platforms with critical evaluation of each.Gene expression profiling in patients with carcinoma of unknown primary site: from translational research to standard of care.The role of microRNA in castration-resistant prostate cancer.Enhancing identification of cancer types via lowly-expressed microRNAs.Paclitaxel/carboplatin with or without belinostat as empiric first-line treatment for patients with carcinoma of unknown primary site: A randomized, phase 2 trial.Accurate classification of metastatic brain tumors using a novel microRNA-based test.Cost-effectiveness of using a gene expression profiling test to aid in identifying the primary tumour in patients with cancer of unknown primary.Serum miR-483-5p as a potential biomarker to detect hepatocellular carcinoma.Development and validation of a microRNA based diagnostic assay for primary tumor site classification of liver core biopsies.A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma.How novel molecular diagnostic technologies and biomarkers are revolutionizing genetic testing and patient care.Predicting progression of bladder urothelial carcinoma using microRNA expression.The clinical significance of occult gynecologic primary tumours in metastatic cancer.Prognostic value of the microRNA-214 in multiple human cancers: a meta-analysis of observational studies.The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer.Serum levels of microRNAs in patients with heart failure.
P2860
Q24625843-8AB81501-8684-40AD-B0B6-8BBAE87366B5Q27005811-ECB415E1-618F-4335-BEA4-CBDE0141D8ECQ33938274-A8B24CEE-F864-4628-B027-8908C21BC7F2Q34031213-53BB19CD-A8C6-4C06-A0BB-2133FA5EB6C3Q34219266-2DCE8209-35D4-4FFD-A69C-BEFDEFA22C57Q34760576-4DA702B4-0E2D-446C-BD06-DB4D2595016DQ34768554-8A9BD575-7F3A-4F67-A213-B0867E8FCA2DQ35034340-B1A47000-DF4F-43EF-B757-01B1F8CF1E67Q35075757-C6513D01-0492-4993-B271-F765166232AAQ35169263-2B6DC8C2-9D4D-4ABD-9814-A21C15725379Q35190111-2ABEBC20-F776-4287-A36E-0D000CE3AC47Q35704188-BFC447E9-115F-4C4F-9D54-15B56DA32DB6Q35738706-ABE26FF6-C311-4F2D-BC0E-C789240D2566Q36051505-0B46C33D-8CCA-47C4-B06B-237F2862DC9CQ36082773-28A5A98F-A676-472A-8AF1-F47F0B964C6FQ37106641-83842DC0-B2F6-4F50-B5AE-B261748BE350Q37317218-9E2A23F8-FCA9-4596-98FA-787FD84689BCQ37607002-FE3A2D4A-D11A-44D2-9264-D0866BF20EF2Q37809868-977622E6-C3F6-4B95-B99C-2F65B5667DBFQ37869934-391EF027-DF20-4BA0-B2DD-FC4A686DBF0FQ37951872-B047B6F7-823B-4122-BB7F-F320484019F5Q38056383-4E0B47AC-A6B2-4AE7-88C5-B4D7E65DC9F9Q38088409-8BE3040B-FC5E-42CA-A42E-0BF6C723088AQ38163463-C73F6BB6-35C3-401C-BE77-109243405791Q38184384-3A8072CF-770D-4863-AD4D-BCE4D810A03EQ38220789-EAA6B07D-593B-4150-8C95-E39CABAA5E4DQ38853181-107E6AEC-63E7-4A74-887E-F71DCCA32F9AQ39051716-9CAC9EE4-33F7-40F4-95A9-7C6958D52685Q39511443-2C5A3406-8A6B-4F92-84AB-0E0B37C65C1FQ39885004-79B0BA64-EA8A-4991-B0CD-299AADD7B13CQ40707609-9A2F4705-0ACF-452C-A1A8-0B7B4A0786A3Q41135852-49AA0D4D-0192-45EC-BF62-82394D8D41B0Q42398312-4174722B-6E4C-40F7-A09C-C0A1EF7E124DQ43494882-662E447B-04E7-41E9-9CC6-5F13DD2C496AQ43603006-6EC76912-AC48-4E42-AACD-65B6814DB035Q45769261-61760876-1013-4A67-B5EF-01FF421AD359Q47136412-992A3ACB-341F-4F09-9356-9DE2E95B007FQ48682005-61FCACA4-EDDE-4B2C-9537-6242944EC26FQ54336789-954BE327-0E6E-42FA-9DC2-004E9FEC36CF
P2860
Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Validation of a microRNA-based ...... cation of tumor tissue origin.
@en
Validation of a microRNA-based ...... cation of tumor tissue origin.
@nl
type
label
Validation of a microRNA-based ...... cation of tumor tissue origin.
@en
Validation of a microRNA-based ...... cation of tumor tissue origin.
@nl
prefLabel
Validation of a microRNA-based ...... cation of tumor tissue origin.
@en
Validation of a microRNA-based ...... cation of tumor tissue origin.
@nl
P2093
P2860
P1433
P1476
Validation of a microRNA-based ...... cation of tumor tissue origin.
@en
P2093
Alexander Faerman
Ayelet Chajut
Danit Lebanony
Dvora Nass
Eran Goren
Hila Benjamin
Ilit Leizerman
Iris Barshack
Karin Ashkenazi
P2860
P2888
P304
P356
10.1038/MODPATHOL.2010.57
P577
2010-03-26T00:00:00Z